"I would like to express gratitude to our regulatory authority for their sense of urgency, which included reducing turnaround time to process applications for registration of ... (the) COVID-19 vaccine," Mamoloko Kubayi said in a statement. After initial doubts owing to a lack of transparency in clinical trial data, Sinovac Biotech's COVID-19 vaccine is emerging as a powerful tool against the virus. The EFF on Saturday said the approval of the Sinovac vaccine was "long overdue." China, where the coronavirus first surfaced in the central city of Wuhan in late 2019, has supplied more than 480 million vaccine doses to other nations. A statement from the Chinese embassy in South Africa said 2.5 million vaccines had been approved for delivery.

Source: bd News24 July 03, 2021 11:26 UTC